Home › Therapeutic areas › Immunology › Hereditary Angioedema

Hereditary Angioedema (3 companies)

Companies with an active program in Hereditary Angioedema.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
BCRX Biocryst Pharmaceuticals DermatologyImmunology+1 Rare 2 Approved $1.93B 4
NTLA Intellia Therapeutics CardiovascularImmunology Rare 1 NDA Submitted $1.37B 3
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 1 Approved $4.49B 29